Clinical trials
Active, not recruiting Alzheimer Disease trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 3 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 3 |
| Ludwig-Maximilians - University of Munich | 2 |
| Washington University School of Medicine | 2 |
| Acumen Pharmaceuticals | 1 |
| AriBio Co., Ltd. | 1 |
| Eisai Inc. | 1 |
| Janssen Pharmaceutica N.V., Belgium | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 11 |
| Cognitive Dysfunction | 4 |
| Dementia | 3 |
| Brain Ischemia | 1 |
| Cognition Disorders | 1 |
| Dementia, Vascular | 1 |
| Hemorrhagic Stroke | 1 |
| Intracranial Hemorrhages | 1 |
| Ischemic Stroke | 1 |
| Memory Disorders | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.